Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras-related protein Rab-7b (RAB7B) is a small GTPase of the Rab family primarily involved in the regulation of intracellular membrane trafficking, including the transport of cargo from late endosomes to the trans-Golgi network and lysosomes[2][3][5]. RAB7B is selectively expressed in monocytic cells, is important for managing inflammatory signaling through promoting the degradation of Toll-like receptor 4 (TLR4), and modulates autophagic flux by interacting with components such as Atg4B[1][3]. In addition to roles in immune responses and vesicle transport, RAB7B also influences actin cytoskeleton organization and cell migration[1][2]. Some studies have linked RAB7B expression or function to disease processes such as cancer (via autophagy regulation), inflammation, and infection, mostly through its regulatory effects on endosomal and lysosomal pathways[1][2][5]. There are currently no recognized drugs or therapeutic compounds that selectively target RAB7B, and it is not considered a major direct therapeutic target in current biomedical literature[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras-related protein Rab-7b (RAB7B).